Key result
RXR variants rs3132294, rs2651860, and rs1128977 were not associated with dyslipidemia risk (rs1128977 T-allele OR 1.058, P=0.701), though rs1128977 correlated with lower HDL-C and higher BMI (P<0.05).
Why the study?
The exact cause of dyslipidemia remains unknown, and although retinoid X receptor genes are associated with lipid homeostasis, the role of specific RXRA and RXRG single nucleotide polymorphisms in genetic susceptibility to dyslipidemia in an Iranian population needed investigation.
Case-Control (n=391)
No
Null associations do not support RXR genotyping for dyslipidemia risk; leaves open rs1128977 links to HDL-C and BMI.
Background Dyslipidemia is a complex trait that is influenced by various genetic and environmental factors. While the exact cause of dyslipidemia is still unknown, some studies have shown that genetic factors such as single nucleotide polymorphisms (SNPs) have been primarily associated with dyslipidemia. Based on the available data, it appears that retinoid X receptor (RXR) genes are jointly or separately associated with lipid homeostasis and that SNPs may affect RXR gene functions in lipid metabolism. Methods To study the possible role of the RXR genes in genetic susceptibility of dyslipidemia, three selected polymorphisms, rs3132294 located in RXRA (RXR-alpha) gene and rs2651860 and rs1128977 located in RXRG (RXR-gamma) gene, were investigated in 391 individuals with the use of tetra-primer amplification refractory mutation system polymerase chain reaction (T-ARMS PCR) method. Results For the rs3132294 SNP, the genotype frequencies in the case group were GG 58.5%, GA 33.2%, and AA 8.3%, and in the control group, they were GG 51.8%, GA 36.3%, and AA 11.9%. The genotype distribution of rs2651860 SNP in the case group were TT 43.2%, TG 52.1%, and GG 4.7%, and in the control group, they were TT 50.8%, TG 46.2%, and GG 3%. Genotype frequencies for the rs1128977 SNP in the case group were CC 34.7%, CT 47.6% and TT 17.7%, compared with CC 37.8%, CT 44.3%, and TT 17.9% in the control group. When the clinical characteristics of the case and control groups were stratified by allele carrier status for each SNP, the rs1128977 SNP was associated with increased levels of HDL-cholesterol, body mass index, waist circumference, and diastolic blood pressure (P< 0.05). In contrast, the alleles of the rs2651860 and rs3132294 SNP were not associated with an increased prevalence of dyslipidemia or clinical characteristics in the case group compared to the control group. Conclusion The present study suggests that rs1128977 SNP in the RXRG gene may affect the clinical characteristics in cases. However, further genetics association studies on large samples are required to validate our findings.
No takes yet. Share an insight, caveat, or question.
Vafaeie et al. (2021) conducted a case-control in Dyslipidemia (n=391). RXR gene polymorphisms (RXRG rs1128977, RXRG rs2651860, RXRA rs3132294) vs. Wild-type reference alleles/genotypes was evaluated on Association between RXRG rs1128977 T-allele and dyslipidemia (OR 1.058, 95% CI 0.794-1.409, p=0.701). RXR variants rs3132294, rs2651860, and rs1128977 were not associated with dyslipidemia risk (rs1128977 T-allele OR 1.058, P=0.701), though rs1128977 correlated with lower HDL-C and higher BMI (P<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: